Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
202M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
+1.27M
-
Total reported value, excl. options
-
$78.4M
-
Value change
-
+$3.48M
-
Put/Call ratio
-
3.12
-
Number of buys
-
42
-
Number of sells
-
-40
-
Price
-
$5.09
Significant Holders of ATAI Life Sciences N.V. - Common Shares (ATAI) as of Q1 2022
105 filings reported holding ATAI - ATAI Life Sciences N.V. - Common Shares as of Q1 2022.
ATAI Life Sciences N.V. - Common Shares (ATAI) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
of 202M outstanding shares and own 7.64% of the company stock.
Largest 10 shareholders include Alpha Wave Global, LP (2.13M shares), MORGAN STANLEY (1.79M shares), ARK Investment Management LLC (1.68M shares), PURA VIDA INVESTMENTS, LLC (1.28M shares), BlackRock Inc. (1.03M shares), Woodline Partners LP (764K shares), Brown University (530K shares), TWO SIGMA INVESTMENTS, LP (510K shares), GROUP ONE TRADING, L.P. (455K shares), and Mirae Asset Global Investments Co., Ltd. (418K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.